StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd > US$40 million Agreement

<< Previous

Bullboard Posts

Next >>

Comment by Jonnyboy85on Feb 15, 2021 6:17pm

153 Views

Post# 32569787

RE:RE:RE:RE:RE:RE:US$40 million Agreement

Again, the only people that say bashing and pumping doesn't work are the same people saying the shorts don't have an effect lol because those are the people using those strategies and they don't work so great if everyone knows about it do they? Keep it up verifried, like all your own posts with all your pumper/basher accounts, it doesn't matter, I'll be here with a smirk for you every day:)

<< Previous

Bullboard Posts

Next >>

The Market Online’s Weekly Gold Report – Nov. 6, 2024